Parkinson's Disease Treatment in Cuba: CIREN Intensive Neurorehabilitation

Parkinson's disease is a progressive neurodegenerative disorder that affects movement control. It occurs when dopamine-producing neurons in the substantia nigra region of the brain degenerate, leading to characteristic motor symptoms including tremor, rigidity, bradykinesia (slowness of movement), and postural instability. Parkinson's affects over 10 million people worldwide.

The International Center for Neurological Restoration (CIREN) in Havana is one of the world's leading institutions for Parkinson's treatment. CIREN's approach combines pharmacological management with an intensive, multidisciplinary rehabilitation model that delivers 4–6 hours of daily therapy across multiple disciplines — a level of intensity that is distinctive to the Cuban model.

CIREN has treated thousands of international Parkinson's patients over three decades, integrating advanced medical treatments, biotechnology, and comprehensive rehabilitation to improve motor function, reduce symptoms, and enhance quality of life.

The cardinal motor symptoms of Parkinson's disease include resting tremor (typically starting on one side of the body), muscle rigidity, bradykinesia (slowness of voluntary movement), and postural instability. Non-motor symptoms are also common and may include loss of smell, sleep disturbances, constipation, depression, anxiety, and cognitive changes.

Parkinson's is a progressive disease, typically classified into five stages (Hoehn and Yahr scale). Stage 1 involves mild symptoms on one side of the body. Stage 2 affects both sides with minimal balance impairment. Stage 3 marks significant balance impairment with functional independence. Stage 4 involves severe disability but ability to walk/stand unaided. Stage 5 requires wheelchair assistance or bedridden.

Early diagnosis and intervention are important for managing symptoms and maintaining quality of life. CIREN's intensive rehabilitation model is most effective for patients in stages 1–4.

Parkinson's disease is diagnosed clinically based on neurological examination and the presence of cardinal motor symptoms. There is no single definitive test — diagnosis relies on the neurologist's assessment of symptoms, response to dopaminergic medication, and ruling out other conditions.

At CIREN, the diagnostic process includes comprehensive neurological examination, advanced neuroimaging (MRI to rule out other conditions, DAT-SPECT imaging), neuropsychological assessment, and evaluation of motor and non-motor symptom severity using standardized scales (UPDRS, Hoehn and Yahr).

This thorough diagnostic protocol ensures accurate diagnosis and helps the medical team design a personalized treatment plan that addresses each patient's specific symptoms and functional goals.

CIREN's Parkinson's program is built on its signature 'Intensive Multidisciplinary Rehabilitation' model. Patients receive 4–6 hours of daily therapy across multiple disciplines including physical therapy, occupational therapy, speech and language therapy, neuropsychological rehabilitation, and pharmacological management.

The program may also incorporate NeuralCIM® neuroprotective therapy and other Cuban biotechnological approaches designed to support neural health and function. Treatment is highly individualized based on each patient's disease stage, symptom profile, and functional goals.

Programs typically last 4–8 weeks and include regular neurological assessments, medication optimization, rehabilitation therapy sessions, and family education. The intensive, coordinated model often achieves functional improvements that standard rehabilitation frequency does not.

CIREN treats Parkinson's patients in stages 1–4 of the Hoehn and Yahr scale. Patients with advanced stage 5 (wheelchair-bound or bedridden) may be evaluated but treatment options may be limited. Eligibility is determined through review of medical history, neurological examination, imaging, and current functional status.

Each case is evaluated individually by CIREN's multidisciplinary team of neurologists, physiatrists, and rehabilitation specialists. A formal recommendation is provided after comprehensive assessment.

To begin the eligibility review, submit recent brain MRI, neurologist's diagnosis, UPDRS assessment if available, current medication list, and a summary of functional status through our consultation form.

Parkinson's treatment programs at CIREN typically last 4–8 weeks. International patients receive comprehensive logistical support including medical visa assistance, airport reception, accommodation near CIREN, translation services, and ground transportation.

A detailed cost estimate is provided after medical review. The program includes neurological consultations, rehabilitation therapy, diagnostic monitoring, medications, accommodation, and logistics. Costs vary based on program duration, therapy intensity, and individual medical needs.

Family members are encouraged to accompany patients, and our team coordinates all arrangements including family accommodation and support services throughout the treatment period.